Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AlphaFold Kinase Optimizer: Enhancing Virtual Screening Performance Through Automated Refinement of AlphaFold-Based Kinase Structures. | Proteins | 2026 | 40955709 | PubTator, text mining | PubMed |
| Correction: TTK promotes mitophagy by regulating ULK1 phosphorylation and pre-mRNA splicing to inhibit mitochondrial apoptosis in bladder cancer. | Cell Death Differ | 2026 | 40890347 | PubTator, text mining | PubMed |
| Corrigendum to "High glucose-induced mitochondrial fission drives pancreatic cancer progression through the H3K18la/TTK/BUB1B signal pathway" [Cell Signal, 135 (2025), 112027]. | Cell Signal | 2026 | 40883118 | PubTator, text mining | PubMed |
| Decoding PRTFDC1's Role in Lung Adenocarcinoma: From Gene Expression to Clinical Implications. | Curr Med Chem | 2026 | 40873179 | PubTator, text mining | PubMed |
| Neuronal injury and hepatotoxicity: astrocytes and stellate cells convergence and their role in tissue repair. | Front Neurosci | 2025 | 41710466 | PubTator, text mining | PubMed |
| Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome. | Int J Mol Sci | 2025 | 41516322 | PubTator, text mining | PubMed |
| Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactylation. | BMC Cancer | 2025 | 41353334 | PubTator, text mining | PubMed |
| TIM-3 Promotes Proliferation of Acute Myeloid Leukemia Blasts. | Biomedicines | 2025 | 41301931 | PubTator, text mining | PubMed |
| NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer. | bioRxiv | 2025 | 41292858 | PubTator, text mining | PubMed |
| Potential Biomarkers and Therapeutic Targets of Non-Small Cell Lung Cancer. | Altern Ther Health Med | 2025 | 41289369 | PubTator, text mining | PubMed |
| The scaffold protein PRR14L links the PP2A-TACC3 axis to mitotic fidelity and sensitivity to MPS1 inhibition. | bioRxiv | 2025 | 41279925 | PubTator, text mining | PubMed |
| Exploring the mechanism of Stephania tetrandra S. Moore in the treatment of cisplatin resistance against ovarian cancer through integration of network pharmacology and molecular docking. | Medicine (Baltimore) | 2025 | 41239601 | PubTator, text mining | PubMed |
| Identification of Prognostic Gene Signatures for Survival of Patients With Phaeochromocytoma, Paraganglioma, and Other Tumor Types. | Cancer Diagn Progn | 2025 | 41179328 | PubTator, text mining | PubMed |
| TTK Defines a High-Risk Oral Squamous Cell Carcinoma Subtype Through Dual mTORC1/NF-κB Activation. | Int Dent J | 2025 | 41092836 | PubTator, text mining | PubMed |
| HIF1A-mediated pathways promote euploid cell survival in chromosomally mosaic embryos. | Elife | 2025 | 41086100 | PubTator, text mining | PubMed |
| Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status. | Open Life Sci | 2025 | 41079598 | PubTator, text mining | PubMed |
| Bioinformatics analysis of immune infiltration and cell cycle hub genes in atopic dermatitis. | Biochem Biophys Rep | 2025 | 40989718 | PubTator, text mining | PubMed |
| Estimating population structure using epigenome-wide methylation data. | medRxiv | 2025 | 40950500 | PubTator, text mining | PubMed |
| The BUB1 and BUBR1 paralogs scaffold the kinetochore fibrous corona. | Sci Adv | 2025 | 40938979 | PubTator, text mining | PubMed |
| The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cells. | Nat Commun | 2025 | 40866357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=5